T-cell acute lymphoblastic leukemia as a secondary leukemia after a 3-year remission of acute myelocytic leukemia

International Journal of Hematology

Volumn 77, Issue 5, 2003, Pages 518-521

  Tsuboi, Kazuya ^a,b   Komatsu, Hirokazu ^a   Miwa, Hiroshi ^b   Iida, Shinsuke ^a   Banno, Shougo ^a   Wakita, Atsushi ^a   Nitta, Masakazu ^b   Ueda, Ryuzo ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Chromosome 6q23; Secondary T ALL; TCR gene; TCR gene

Indexed keywords

ALKYLATING AGENT; CYTARABINE; DAUNORUBICIN; ENOCITABINE; ETOPOSIDE; GYRASE INHIBITOR; MERCAPTOPURINE; MITOXANTRONE; PREDNISOLONE; VINBLASTINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; LEUKEMOGENESIS; T CELL LEUKEMIA; TREATMENT OUTCOME;

EID: 0037670798     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02986622     Document Type: Article

References (14)

1. Pedersen-Bjergaard J, Philip P, Larsen SO, et al. Therapy-related myelodysplasia and acute myeloid leukemia: cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 1993;7:1975-1986.
2. Andersen MK, Christiansen DH, Jensen BA, Ernst P, Hauge G, Pedersen-Bjergaard J. Therapy-related acute lymphoblastic leukemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992. Br J Haematol. 2001;114:539-543.
3. Zeidman A, Dayan DB, Mittelman M. Secondary myelodysplastic syndromes and acute leukemias. Haematologia (Budp). 1995;27:23-28.
4. Pui CH, Relling MV. Topoisomerase II inhibitor-related acute myeloid leukaemia. Br J Haematol. 2000;109:13-23.
5. Leone G, Voso MT, Sica S, Morosetti R, Pagano L. Therapy related leukemias: susceptibility, prevention and treatment. Leuk Lymphoma. 2001;41:255-276.
6. Super HJ, McCabe NR, Thirman MJ, et al. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood. 1993;82:3705-3711.
7. Dawson L, Slater R, Hagemeijer A, Langerak W, Willemze R, Kluin-Nelemans JC. Secondary T-acute lymphoblastic leukaemia mimicking blast crisis in chronic myeloid leukaemia. Br J Haematol. 1999;106:104-106.
8. Levendoglu-Tugal O, Weiss R, Ozkaynak MF, et al. T-cell acute lymphoblastic leukemia after renal transplantation in childhood. J Pediatr Hematol Oncol. 1998;20:548-551.
9. Perotti D, Sozzi G, Ferrari A, et al. Cytogenetic and molecular characterization of T-cell acute lymphoblastic leukemia as a second tumor after anaplastic large-cell lymphoma in a boy. Haematologica. 1999;84:554-557.
10. Kaplinsky C, Frisch A, Cohen IJ, et al. T-cell acute lymphoblastic leukemia following therapy of rhabdomyosarcoma. Med Pediatr Oncol. 1992;20:229-231.
11. Liso V, Specchia G, Pannunzio A, Mestice A, Palumbo G, Biondi A. T-cell acute lymphoblastic leukemia occurring in a patient with acute promyelocytic leukemia. Haematologica. 1998;83:471-473.
12. Hwang LY, Baer RJ. The role of chromosome translocations in T cell acute leukemia. Curr Opin Immunol. 1995;7:659-664.
13. Suto Y, Sato Y, Smith SD, Rowley JD, Bohlander SK. A t(6;12) (q23;p13) results in the fusion of ETV6 to a novel gene, STL, in a B-cell ALL cell line. Genes Chromosomes Cancer. 1997;18:254-268.
14. Dastugue N, Duchayne E, Kuhlein E, et al. Acute basophilic leukaemia and translocation t(X;6)(p11;q23). Br J Haematol. 1997;98:170-176.